Promore Pharma AB (publ) PROMO.ST Stock
Promore Pharma AB (publ) Price Chart
Promore Pharma AB (publ) PROMO.ST Financial and Trading Overview
| Promore Pharma AB (publ) stock price | 0.11 SEK |
| Previous Close | 0.16 SEK |
| Open | 0.15 SEK |
| Bid | 0.16 SEK x 0 |
| Ask | 0.16 SEK x 0 |
| Day's Range | 0.15 - 0.16 SEK |
| 52 Week Range | 0.15 - 2 SEK |
| Volume | 164.91K SEK |
| Avg. Volume | 349.67K SEK |
| Market Cap | 9.74M SEK |
| Beta (5Y Monthly) | 0.407279 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PROMO.ST Valuation Measures
| Enterprise Value | 1M SEK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 88.5871 |
| Price/Book (mrq) | 1.4078947 |
| Enterprise Value/Revenue | 9.123 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Promore Pharma AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.407279 |
| 52-Week Change | -85.13% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2 SEK |
| 52 Week Low | 0.15 SEK |
| 50-Day Moving Average | 0.54 SEK |
| 200-Day Moving Average | 0.87 SEK |
PROMO.ST Share Statistics
| Avg. Volume (3 month) | 349.67K SEK |
| Avg. Daily Volume (10-Days) | 172.74K SEK |
| Shares Outstanding | 60.71M |
| Float | 17.99M |
| Short Ratio | N/A |
| % Held by Insiders | 81.31% |
| % Held by Institutions | 2.30% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -23011.81% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -64.81% |
| Return on Equity (ttm) | -129.39% |
Income Statement
| Revenue (ttm) | 110K SEK |
| Revenue Per Share (ttm) | 0.002 SEK |
| Quarterly Revenue Growth (yoy) | 47.79% |
| Gross Profit (ttm) | -15845000 SEK |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -25332000 SEK |
| Diluted EPS (ttm) | -0.41 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.36M SEK |
| Total Cash Per Share (mrq) | 0.15 SEK |
| Total Debt (mrq) | 714K SEK |
| Total Debt/Equity (mrq) | 10.34 SEK |
| Current Ratio (mrq) | 3.968 |
| Book Value Per Share (mrq) | 0.114 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -27081000 SEK |
| Levered Free Cash Flow (ttm) | -17562624 SEK |
Profile of Promore Pharma AB (publ)
| Country | Sweden |
| State | N/A |
| City | Solna |
| Address | Fogdevreten 2 |
| ZIP | 171 65 |
| Phone | 46 8 12 45 48 59 |
| Website | https://www.promorepharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
Promore Pharma AB (publ), a biopharmaceutical company, develops peptide-based drug candidates in Sweden and internationally. Its product candidates include PXL01 that is in Phase IIa study for the prevention of post-surgical adhesions and scars, and for the prevention of dermal scars, as well as for tendon repair surgery in the hand; and LL-37, which has completed Phase IIb clinical studies for treating patients with venous leg ulcers, stimulate the healing of chronic wounds, and for the treatment of diabetic foot ulcers. The company was formerly known as Lipopeptide AB and changed its name to Promore Pharma AB (publ) in January 2017. Promore Pharma AB (publ) was founded in 2002 and is headquartered in Solna, Sweden.
Q&A For Promore Pharma AB (publ) Stock
What is a current PROMO.ST stock price?
Promore Pharma AB (publ) PROMO.ST stock price today per share is 0.11 SEK.
How to purchase Promore Pharma AB (publ) stock?
You can buy PROMO.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Promore Pharma AB (publ)?
The stock symbol or ticker of Promore Pharma AB (publ) is PROMO.ST.
Which industry does the Promore Pharma AB (publ) company belong to?
The Promore Pharma AB (publ) industry is Biotechnology.
How many shares does Promore Pharma AB (publ) have in circulation?
The max supply of Promore Pharma AB (publ) shares is 2.67B.
What is Promore Pharma AB (publ) Price to Earnings Ratio (PE Ratio)?
Promore Pharma AB (publ) PE Ratio is 0.00000000 now.
What was Promore Pharma AB (publ) earnings per share over the trailing 12 months (TTM)?
Promore Pharma AB (publ) EPS is 0 SEK over the trailing 12 months.
Which sector does the Promore Pharma AB (publ) company belong to?
The Promore Pharma AB (publ) sector is Healthcare.
Promore Pharma AB (publ) PROMO.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North All-Share SEK FIRSTNORTHSEK | 123.34 SEK 12.04 USD |
-0.14
|
— — | — — | — — | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 97.96 DKK 14.36 USD |
-0.62
|
— — | — — | — — | — - | — — |
| First North Sweden SEK GI FNSESEKGI | 1956.89 SEK 191.02 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1570.14 EUR 1716.38 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care GI FN20GI | 917.04 EUR 1002.44 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 97.9 EUR 107.01 USD |
-0.64
|
— — | — — | — — | — - | — — |
| First North Sweden SEK PI FNSESEKPI | 1843.91 SEK 179.99 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1479.5 EUR 1617.29 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care PI FN20PI | 912.9 EUR 997.92 USD |
-1.17
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}